GlassScriptPhysician profile
Brian S Rizzo
NPI 1720067390
$46,709.62
in general payments reported to CMS, 2019-2025
26 companies · $39K in 2025
The $39K reported for 2025 was more than what 99% of Facial Plastic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118 · 2020: $278 · 2021: $304 · 2022: $2,141 · 2023: $3,178 · 2024: $1,585 · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $38K · Travel and Lodging: $4,054 · Food and Beverage: $2,150 · Education: $57.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $37,607.35 |
| Travel and Lodging | $4,054.30 |
| Food and Beverage | $2,150.08 |
| Education | $57.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $37,607.35 | 2025 | Gyrus Acmi, Evonos, Rhino-Laryngo Fiberscope |
| Acclarent, INC | $4,771.77 | 2022-2024 | Acclarent Balloon Inflation Device, Trudi Nav Suction, Relieva Spinplus |
| Integra Lifesciences Corporation | $1,057.94 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Medical Device Business Services, INC. | $796.87 | 2022 | |
| Glaxosmithkline, LLC. | $543.83 | 2021-2025 | Nucala |
| Stryker Corporation | $365.43 | 2019-2025 | Scopis Ent, Audion Et Dilation System, Xpress Loprofile |
| Genzyme Corporation | $364.61 | 2019-2025 | |
| Medtronic, INC. | $287.44 | 2021-2024 | Sinuva, Nuvent |
| Aerin Medical INC. | $228.45 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $132.59 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $105.89 | 2019-2025 | Dupixent |
| Sanofi-Aventis U.S. LLC | $57.48 | 2025 | |
| Ethicon US, LLC | $54.20 | 2021-2025 | Surgiflo Hemostatic Matrix |
| Intersect Ent, INC. | $50.95 | 2019-2020 | |
| Baxter Healthcare | $43.45 | 2024 | Perclot |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xoran Technologies LLC | $34.90 | 2020 | |
| Precigen, INC. | $34.00 | 2025 | |
| Hikma Pharmaceuticals USA | $27.30 | 2024 | Ryaltris |
| Phathom Pharmaceuticals, INC. | $24.55 | 2025 | Voquezna |
| Acera Surgical, INC. | $22.86 | 2023 | Restrata Wound Matrix |
| Takeda Pharmaceuticals U.S.A., INC. | $17.69 | 2024 | Elaprase |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.57 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $17.33 | 2025 | Tezspire |
| Optinose US, INC. | $15.81 | 2020 | |
| Eyevance Pharmaceuticals LLC | $14.99 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Rizzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.